Amgen (AMGN)
(Delayed Data from NSDQ)
$334.30 USD
-1.31 (-0.39%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $336.00 +1.70 (0.51%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMGN 334.30 -1.31(-0.39%)
Will AMGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMGN
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
AstraZeneca (AZN) Beats on Q2 Earnings & Sales, Ups '24 View
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Lies in Store for Healthcare ETFs in Q2 Earnings?
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?
Other News for AMGN
Market Whales and Their Recent Bets on AMGN Options
September 6th Options Now Available For Amgen (AMGN)
Viking sends Lilly, Novo lower as obesity drug enters late-stage program
HRTS: Generating Alpha In Obesity Treatment
3 Fabulous Growth Stocks to Buy and Hold Forever